Symbiot™ Covered Stent System

Each year, approximately 600,000 coronary artery bypass graft surgeries are performed worldwide to relieve angina in patients suffering from coronary artery disease. Frequently, saphenous veins are taken from the leg and used as grafts in this surgery. Of the patients who undergo this procedure, nearly 250,000 annually develop saphenous vein graft (SVG) disease. Conventional stents are not specifically designed to treat this disease and are often associated with procedural embolization and high restenosis rates. The Symbiot stent system is specifically designed to treat SVG disease.